1. Gsi Xx
2. Iminostilbene
3. Iminostilbene, 10-(13)c-labeled
1. Iminostilbene
2. 5h-dibenzo[b,f]azepine
3. 5h-dibenz[b,f]azepine
4. Dibenz(b,f)azepine
5. 5h-dibenz(b,f)azepine
6. Dibenz[b,f]azepine
7. 5h-dibenzo(b,f)azepine
8. O,o'-iminostilbene
9. 5h-dibenz[b,f]azepin
10. 5h-dibenzazepine
11. Einecs 205-970-0
12. Unii-j411kqj8c2
13. J411kqj8c2
14. Chebi:47802
15. Nsc-123458
16. Dtxsid90871625
17. Ec 205-970-0
18. Carbamazepine Impurity D [ip]
19. Rp-9989
20. 5h-dibenz(b,f)azepin
21. Carbamazepine Impurity D [ep Impurity]
22. Oxcarbazepine Impurity E [ep Impurity]
23. Carbamazepine Impurity D (ip)
24. Carbamazepine Impurity D (ep Impurity)
25. Oxcarbazepine Impurity E (ep Impurity)
26. Gsi Xx
27. Dtxcid4020458
28. Dtxcid60819276
29. Iminostilbene, 10-(13)c-labeled
30. (2s)-2-((2-(3,5-difluorophenyl)acetyl)amino)-n-((7s)-5-methyl-6-oxo-7h-benzo(d)(1)benzazepin-7-yl)propanamide
31. Dtxsid6040458
32. Lcgtwrljtmhiqz-uhfffaoysa-n
33. 256-96-2
34. 2,2'-iminostilbene
35. 2,3,6,7-dibenzazepine
36. Stilbene, 2,2'-imino-
37. 11h-benzo[b][1]benzazepine
38. Iminostilbene-d2
39. 5-azadibenzo(a,e)cycloheptatriene
40. Mfcd00005071
41. Nsc 123458
42. Mls000737549
43. 5-azadibenzo[a,e]cycloheptatriene
44. 5h-dibenzo[b,f]azepine (iminostilbene)
45. 5h-dibenzo[b,f]azepine;oxcarbazepine Ep Impurity E;
46. Stilbene,2'-imino-
47. 2,6,7-dibenzazepine
48. Iminostilbene (standard)
49. Oprea1_371695
50. Schembl75288
51. (z)-5h-dibenzo[b,f]azepine
52. Chembl243596
53. 5h-dibenz[b,f]azepine, 97%
54. Schembl10434951
55. Hy-n7064r
56. Hms1664f10
57. Hms2769i10
58. Hms3886o07
59. Hy-n7064
60. Str04241
61. Nsc123458
62. S4973
63. Akos015894918
64. Ccg-266525
65. Cs-w015765
66. Fi24557
67. Ncgc00246953-01
68. Ac-11074
69. Smr000065475
70. Db-046759
71. I0414
72. Ns00000328
73. Ns00124786
74. En300-176476
75. F15408
76. Q61388
77. 5h-dibenz[b,f]azepine, Purum, >=97.0% (nt)
78. Z56754946
79. 2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaene
80. 5h-dibenz[b,f]azepine;2,2'-iminostilbene;5-azadibenzo[a,e]cycloheptatriene
81. 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene
82. Iminostilbene; P-toluenesulfonic Acid Sodium Salt; Toluene-4-sulfonic Acid Sodium Salt; 4-methylbenzenesulfonic Acid Sodium Salt
| Molecular Weight | 193.24 g/mol |
|---|---|
| Molecular Formula | C14H11N |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 12 |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 222 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Gamma Secretase Inhibitors and Modulators
Agents that suppress GAMMA-SECRETASE by inhibiting or modulating its activities. Targeted enzymatic activities include its involvement in accumulation of toxic AMYLOID BETA-PEPTIDES (e.g., Aβ42) in ALZHEIMER DISEASE and activation of NOTCH RECEPTOR mediated SIGNAL PATHWAYS in certain cancer types. (See all compounds classified as Gamma Secretase Inhibitors and Modulators.)
N03AF01
S66 | EAWAGTPS | Parent-Transformation Product Pairs from Eawag | DOI:10.5281/zenodo.3754448
